Literature DB >> 24589157

Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challenge.

Praveen Ramakrishnan Geethakumari1, Marc S Hoffmann2, Naveen Pemmaraju2, Shimin Hu3, Jeffrey L Jorgensen3, Susan O'Brien2, Naval Daver4.   

Abstract

Entities:  

Keywords:  CXCR4/SDF-1 signaling; Extramedullary; Lymphoblastic lymphoma; Multi-agent chemotherapy; Multiplanar flow cytometry

Mesh：

Year:  2014        PMID： 24589157      PMCID： PMC4403758          DOI： 10.1016/j.clml.2014.01.004

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  27 in total

1.  Guess what. B-cell acute lymphoblastic leukemia with aleukemic leukemia cutis.

Authors:  H Kishimoto; Y Furui; K Nishioka
Journal:  Eur J Dermatol       Date:  2001 Mar-Apr       Impact factor: 3.328

2.  Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

Authors:  A Reiter; M Schrappe; W D Ludwig; M Tiemann; R Parwaresch; M Zimmermann; E Schirg; G Henze; G Schellong; H Gadner; H Riehm
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

3.  Aleukemic leukemia masquerading as renal masses: a rare presentation of adult lymphoblastic leukemia.

Authors:  W Y Au; Y L Kwong; S K Ma
Journal:  Am J Hematol       Date:  2000-12       Impact factor: 10.047

Review 4.  Lymphoblastic lymphoma.

Authors:  Sergio Cortelazzo; Maurilio Ponzoni; Andrés J M Ferreri; Dieter Hoelzer
Journal:  Crit Rev Oncol Hematol       Date:  2011-01-26       Impact factor: 6.312

Review 5.  Acute leukemia presenting with extramedullary diseases and completely normal hemogram: an extremely unusual manifestation unique to pre-B ALL.

Authors:  Chih-Cheng Chen; Hsu-Huei Weng; Cih-En Hwang; Chang-Hsien Lu; Ping-Tsung Chen; Jyh-Pyng Gau
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

Review 6.  Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.

Authors:  A Maitra; R W McKenna; A G Weinberg; N R Schneider; S H Kroft
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

7.  Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

Authors:  Graça M Dores; Susan S Devesa; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

8.  Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.

Authors:  Stéphane Ducassou; Céline Ferlay; Christophe Bergeron; Sandrine Girard; Geneviève Laureys; Hélène Pacquement; Dominique Plantaz; Patrick Lutz; Jean-Pierre Vannier; Anna Uyttebroeck; Yves Bertrand
Journal:  Br J Haematol       Date:  2011-01-07       Impact factor: 6.998

9.  Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.

Authors:  P Lin; D Jones; D M Dorfman; L J Medeiros
Journal:  Am J Surg Pathol       Date:  2000-11       Impact factor: 6.394

Review 10.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113
View more
  5 in total

1.  Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.

Authors:  Elizabeth M Holland; Bonnie Yates; Alex Ling; Constance M Yuan; Hao-Wei Wang; Maryalice Stetler-Stevenson; Michael LaLoggia; John C Molina; Daniel A Lichtenstein; Daniel W Lee; John A Ligon; Haneen Shalabi; Mark A Ahlman; Nirali N Shah
Journal:  Blood Adv       Date:  2022-04-12

2.  Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.

Authors:  Sabine Kayser; Chiara Sartor; Marlise R Luskin; Jonathan Webster; Fabio Giglio; Nydia Panitz; Andrew M Brunner; Matthias Fante; Christoph Lutz; Daniel Wolff; Anthony D Ho; Mark J Levis; Richard F Schlenk; Cristina Papayannidis
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047

3.  Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.

Authors:  Xiaoning Li; Weijie Cao; Suping Zhang; Li Li; Yingmei Li; Zhongxing Jiang; Dingming Wan; Jifeng Yu
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

4.  Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.

Authors:  Dongmei Fan; Wei Li; Yuqi Yang; Xiaolong Zhang; Qing Zhang; Yan Yan; Ming Yang; Jianxiang Wang; Dongsheng Xiong
Journal:  J Hematol Oncol       Date:  2015-10-06       Impact factor: 17.388

5.  Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin.

Authors:  Wellington Fernandes da Silva; Gabriel Lacerda Marquez; Rafael Calil Salim; Vanderson Rocha
Journal:  Hematol Transfus Cell Ther       Date:  2019-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.